{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:41:04Z","timestamp":1776238864449,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"4th Priority Discipline Development Program of Jiangsu Higher Education Institutions","award":["Jiangsu Education Department [2023] No. 11"],"award-info":[{"award-number":["Jiangsu Education Department [2023] No. 11"]}]},{"name":"Jiangsu Provincial Hospital Association Hospital Management Innovation Research Project","award":["JSYGY-2-2023-551"],"award-info":[{"award-number":["JSYGY-2-2023-551"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00520-026-10598-x","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:10:08Z","timestamp":1774494608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multidimensional nomogram for prediction of cardiovascular disease risk in cancer survivors"],"prefix":"10.1007","volume":"34","author":[{"given":"Xin-Ru","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jie","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Yi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"10598_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, Kramer J, Siegel RL (2022) Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 72:409\u2013436. https:\/\/doi.org\/10.3322\/caac.21731","journal-title":"CA Cancer J Clin"},{"key":"10598_CR2","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","volume":"40","author":"KM Sturgeon","year":"2019","unstructured":"Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C, Kelly SP, Zaorsky NG (2019) A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J 40:3889\u20133897. https:\/\/doi.org\/10.1093\/eurheartj\/ehz766","journal-title":"Eur Heart J"},{"key":"10598_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jacc.2022.04.042","volume":"80","author":"R Florido","year":"2022","unstructured":"Florido R, Daya NR, Ndumele CE et al (2022) Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study. J Am Coll Cardiol 80:22\u201332. https:\/\/doi.org\/10.1016\/j.jacc.2022.04.042","journal-title":"J Am Coll Cardiol"},{"key":"10598_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15639-5","volume":"11","author":"KC Stoltzfus","year":"2020","unstructured":"Stoltzfus KC, Zhang Y, Sturgeon K, Sinoway LI, Trifiletti DM, Chinchilli VM, Zaorsky NG (2020) Fatal heart disease among cancer patients. Nat Commun 11:2011. https:\/\/doi.org\/10.1038\/s41467-020-15639-5","journal-title":"Nat Commun"},{"key":"10598_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jaccao.2022.01.100","volume":"4","author":"DI Paterson","year":"2022","unstructured":"Paterson DI, Wiebe N, Cheung WY, Mackey JR, Pituskin E, Reiman A, Tonelli M (2022) Incident cardiovascular disease among adults with cancer: a population-based cohort study. JACC CardioOncol 4:85\u201394. https:\/\/doi.org\/10.1016\/j.jaccao.2022.01.100","journal-title":"JACC CardioOncol"},{"key":"10598_CR6","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/circresaha.121.318051","volume":"128","author":"DCH van Dorst","year":"2021","unstructured":"van Dorst DCH, Dobbin SJH, Neves KB, Herrmann J, Herrmann SM, Versmissen J, Mathijssen RHJ, Danser AHJ, Lang NN (2021) Hypertension and prohypertensive antineoplastic therapies in cancer patients. Circ Res 128:1040\u20131061. https:\/\/doi.org\/10.1161\/circresaha.121.318051","journal-title":"Circ Res"},{"key":"10598_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jaccao.2019.11.009","volume":"1","author":"JB Cohen","year":"2019","unstructured":"Cohen JB, Geara AS, Hogan JJ, Townsend RR (2019) Hypertension in cancer patients and survivors: epidemiology, diagnosis, and management. JACC CardioOncol 1:238\u2013251. https:\/\/doi.org\/10.1016\/j.jaccao.2019.11.009","journal-title":"JACC CardioOncol"},{"key":"10598_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/cvr\/cvad017","volume":"119","author":"M Z\u0105bczyk","year":"2023","unstructured":"Z\u0105bczyk M, Ari\u00ebns RAS, Undas A (2023) Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice. Cardiovasc Res 119:94\u2013111. https:\/\/doi.org\/10.1093\/cvr\/cvad017","journal-title":"Cardiovasc Res"},{"key":"10598_CR9","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1136\/gutjnl-2020-321661","volume":"70","author":"H Chen","year":"2021","unstructured":"Chen H, Zheng X, Zong X et al (2021) Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer. Gut 70:1147\u20131154. https:\/\/doi.org\/10.1136\/gutjnl-2020-321661","journal-title":"Gut"},{"key":"10598_CR10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/circulationaha.123.067626","volume":"149","author":"SS Khan","year":"2024","unstructured":"Khan SS, Matsushita K, Sang Y et al (2024) Development and validation of the American Heart Association\u2019s PREVENT equations. Circulation 149:430\u2013449. https:\/\/doi.org\/10.1161\/circulationaha.123.067626","journal-title":"Circulation"},{"key":"10598_CR11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.4093\/dmj.2021.0077","volume":"45","author":"DS Kim","year":"2021","unstructured":"Kim DS, Scherer PE (2021) Obesity, diabetes, and increased cancer progression. Diabetes Metab J 45:799\u2013812. https:\/\/doi.org\/10.4093\/dmj.2021.0077","journal-title":"Diabetes Metab J"},{"key":"10598_CR12","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1161\/circresaha.120.317240","volume":"126","author":"KJ Moore","year":"2020","unstructured":"Moore KJ, Shah R (2020) Introduction to the obesity, metabolic syndrome, and CVD compendium. Circ Res 126:1475\u20131476. https:\/\/doi.org\/10.1161\/circresaha.120.317240","journal-title":"Circ Res"},{"key":"10598_CR13","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/jamaoncol.2024.1939","volume":"10","author":"NT Le","year":"2024","unstructured":"Le NT, Phan CV, Pham YT, Le PH, Dao HV, Nguyen LC, Yuan JM, Luu HN (2024) Waterpipe tobacco smoking and risk of cancer mortality. JAMA Oncol 10:1237\u20131244. https:\/\/doi.org\/10.1001\/jamaoncol.2024.1939","journal-title":"JAMA Oncol"},{"key":"10598_CR14","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1093\/eurheartj\/ehaa460","volume":"41","author":"T M\u00fcnzel","year":"2020","unstructured":"M\u00fcnzel T, Hahad O, Kuntic M, Keaney JF, Deanfield JE, Daiber A (2020) Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes. Eur Heart J 41:4057\u20134070. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa460","journal-title":"Eur Heart J"},{"key":"10598_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41569-024-01017-x","volume":"21","author":"NS Wilcox","year":"2024","unstructured":"Wilcox NS, Amit U, Reibel JB, Berlin E, Howell K, Ky B (2024) Cardiovascular disease and cancer: shared risk factors and mechanisms. Nat Rev Cardiol 21:617\u2013631. https:\/\/doi.org\/10.1038\/s41569-024-01017-x","journal-title":"Nat Rev Cardiol"},{"key":"10598_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13030512","author":"B Barone","year":"2023","unstructured":"Barone B, Finati M, Cinelli F et al (2023) Bladder cancer and risk factors: data from a multi-institutional long-term analysis on cardiovascular disease and cancer incidence. J Pers Med. https:\/\/doi.org\/10.3390\/jpm13030512","journal-title":"J Pers Med"},{"key":"10598_CR17","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1093\/jnci\/djae107","volume":"116","author":"JB Vo","year":"2024","unstructured":"Vo JB, Ramin C, Veiga LHS et al (2024) Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors. J Natl Cancer Inst 116:1384\u20131394. https:\/\/doi.org\/10.1093\/jnci\/djae107","journal-title":"J Natl Cancer Inst"},{"key":"10598_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1200\/jco.21.02613","volume":"41","author":"S de Vries","year":"2023","unstructured":"de Vries S, Haaksma ML, J\u00f3\u017awiak K et al (2023) Development and validation of risk prediction models for coronary heart disease and heart failure after treatment for Hodgkin lymphoma. J Clin Oncol 41:86\u201395. https:\/\/doi.org\/10.1200\/jco.21.02613","journal-title":"J Clin Oncol"},{"key":"10598_CR19","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1002\/cncr.34464","volume":"128","author":"IM Krul","year":"2022","unstructured":"Krul IM, Boekel NB, Kramer I et al (2022) Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma. Cancer 128:4285\u20134295. https:\/\/doi.org\/10.1002\/cncr.34464","journal-title":"Cancer"},{"key":"10598_CR20","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","volume":"17","author":"J Herrmann","year":"2020","unstructured":"Herrmann J (2020) Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia. Nat Rev Cardiol 17:474\u2013502. https:\/\/doi.org\/10.1038\/s41569-020-0348-1","journal-title":"Nat Rev Cardiol"},{"key":"10598_CR21","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.trecan.2024.07.004","volume":"10","author":"X Lin","year":"2024","unstructured":"Lin X, Ma X, Zhao S, Yao J, Han L, Jing Y, Xue X (2024) Cardiovascular toxicity in antitumor therapy: biological and therapeutic insights. Trends Cancer 10:920\u2013934. https:\/\/doi.org\/10.1016\/j.trecan.2024.07.004","journal-title":"Trends Cancer"},{"key":"10598_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41569-020-0347-2","volume":"17","author":"J Herrmann","year":"2020","unstructured":"Herrmann J (2020) Vascular toxic effects of cancer therapies. Nat Rev Cardiol 17:503\u2013522. https:\/\/doi.org\/10.1038\/s41569-020-0347-2","journal-title":"Nat Rev Cardiol"},{"key":"10598_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaccao.2022.01.101","volume":"4","author":"T Omland","year":"2022","unstructured":"Omland T, Heck SL, Gulati G (2022) The role of cardioprotection in cancer therapy cardiotoxicity: JACC: cardioOncology state-of-the-art review. JACC CardioOncol 4:19\u201337. https:\/\/doi.org\/10.1016\/j.jaccao.2022.01.101","journal-title":"JACC CardioOncol"},{"key":"10598_CR24","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/jcsm.13443","volume":"15","author":"K Ueno","year":"2024","unstructured":"Ueno K, Kaneko H, Suzuki Y et al (2024) Metabolic syndrome and cardiovascular disease in cancer survivors. J Cachexia Sarcopenia Muscle 15:1062\u20131071. https:\/\/doi.org\/10.1002\/jcsm.13443","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10598_CR25","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s11912-022-01309-w","volume":"24","author":"J Muhandiramge","year":"2022","unstructured":"Muhandiramge J, Zalcberg JR, van Londen GJ, Warner ET, Carr PR, Haydon A, Orchard SG (2022) Cardiovascular disease in adult cancer survivors: a review of current evidence, strategies for prevention and management, and future directions for cardio-oncology. Curr Oncol Rep 24:1579\u20131592. https:\/\/doi.org\/10.1007\/s11912-022-01309-w","journal-title":"Curr Oncol Rep"},{"key":"10598_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jacc.2022.04.041","volume":"80","author":"AF Yu","year":"2022","unstructured":"Yu AF, Steingart RM (2022) ARIC welcomes cancer survivors into their communities: unraveling the link between cancer and cardiovascular disease. J Am Coll Cardiol 80:33\u201335. https:\/\/doi.org\/10.1016\/j.jacc.2022.04.041","journal-title":"J Am Coll Cardiol"},{"key":"10598_CR27","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/eurjpc\/zwad294","volume":"30","author":"B Gigante","year":"2023","unstructured":"Gigante B, Langley RE, Rocca B (2023) Cancer and cardiovascular diseases: the long, winding and crossing roads. Eur J Prev Cardiol 30:2015\u20132017. https:\/\/doi.org\/10.1093\/eurjpc\/zwad294","journal-title":"Eur J Prev Cardiol"},{"key":"10598_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1265356","volume":"13","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Zhao J, Xie R, Zhang Y, Xu Y, Mao J, Yan C, Sun Y (2023) Association between family income to poverty ratio and HPV infection status among U.S. women aged 20 years and older: a study from NHANES 2003-2016. Front Oncol 13:1265356. https:\/\/doi.org\/10.3389\/fonc.2023.1265356","journal-title":"Front Oncol"},{"key":"10598_CR29","unstructured":"World Health Organization (2024) Obesity and overweight. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. Accessed 19 Mar 2025"},{"key":"10598_CR30","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.jand.2023.05.015","volume":"123","author":"MM Shams-White","year":"2023","unstructured":"Shams-White MM, Pannucci TE, Lerman JL, Herrick KA, Zimmer M, Meyers Mathieu K, Stoody EE, Reedy J (2023) Healthy eating index-2020: review and update process to reflect the dietary guidelines for Americans,2020\u20132025. J Acad Nutr Diet 123:1280\u20131288. https:\/\/doi.org\/10.1016\/j.jand.2023.05.015","journal-title":"J Acad Nutr Diet"},{"key":"10598_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1190934","volume":"14","author":"JJ Li","year":"2023","unstructured":"Li JJ, Zhao SP, Zhao D et al (2023) 2023 Chinese guideline for lipid management. Front Pharmacol 14:1190934. https:\/\/doi.org\/10.3389\/fphar.2023.1190934","journal-title":"Front Pharmacol"},{"key":"10598_CR32","doi-asserted-by":"publisher","first-page":"88531","DOI":"10.1007\/s11356-022-21973-6","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhu Y, Chen Z, Chen S, Fu G, Fu J (2022) Association between electronic cigarettes use and whole blood cell among adults in the USA-a cross-sectional study of National Health and Nutrition Examination Survey analysis. Environ Sci Pollut Res Int 29:88531\u201388539. https:\/\/doi.org\/10.1007\/s11356-022-21973-6","journal-title":"Environ Sci Pollut Res Int"},{"key":"10598_CR33","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606\u2013613. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x","journal-title":"J Gen Intern Med"},{"key":"10598_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1080782","volume":"13","author":"Y You","year":"2022","unstructured":"You Y, Chen Y, Fang W, Li X, Wang R, Liu J, Ma X (2022) The association between sedentary behavior, exercise, and sleep disturbance: a mediation analysis of inflammatory biomarkers. Front Immunol 13:1080782. https:\/\/doi.org\/10.3389\/fimmu.2022.1080782","journal-title":"Front Immunol"},{"key":"10598_CR35","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jacc.2018.05.054","volume":"72","author":"FH Messerli","year":"2018","unstructured":"Messerli FH, Grodzicki T, Messerli A, Bangalore S, Rexhaj E (2018) Age, cardiovascular risk, and blood pressure target. J Am Coll Cardiol 72:818\u2013819. https:\/\/doi.org\/10.1016\/j.jacc.2018.05.054","journal-title":"J Am Coll Cardiol"},{"key":"10598_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jaccao.2024.02.001","volume":"6","author":"D Ioffe","year":"2024","unstructured":"Ioffe D, Bhatia-Patel SC, Gandhi S, Hamad EA, Dotan E (2024) Cardiovascular concerns, cancer treatment, and biological and chronological aging in cancer: JACC family series. JACC CardioOncol 6:143\u2013158. https:\/\/doi.org\/10.1016\/j.jaccao.2024.02.001","journal-title":"JACC CardioOncol"},{"key":"10598_CR37","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.pcad.2019.10.003","volume":"62","author":"MH Miname","year":"2019","unstructured":"Miname MH, Santos RD (2019) Reducing cardiovascular risk in patients with familial hypercholesterolemia: risk prediction and lipid management. Prog Cardiovasc Dis 62:414\u2013422. https:\/\/doi.org\/10.1016\/j.pcad.2019.10.003","journal-title":"Prog Cardiovasc Dis"},{"key":"10598_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000021498","volume":"99","author":"T He","year":"2020","unstructured":"He T, Wang C, Tan Q et al (2020) Adjuvant chemotherapy-associated lipid changes in breast cancer patients: a real-word retrospective analysis. Medicine (Baltimore) 99:e21498. https:\/\/doi.org\/10.1097\/md.0000000000021498","journal-title":"Medicine (Baltimore)"},{"key":"10598_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.925816","volume":"9","author":"R Bhatnagar","year":"2022","unstructured":"Bhatnagar R, Dixit NM, Yang EH, Sallam T (2022) Cancer therapy\u2019s impact on lipid metabolism: mechanisms and future avenues. Front Cardiovasc Med 9:925816. https:\/\/doi.org\/10.3389\/fcvm.2022.925816","journal-title":"Front Cardiovasc Med"},{"key":"10598_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2297-3","volume":"11","author":"ALS Cruz","year":"2020","unstructured":"Cruz ALS, Barreto EA, Fazolini NPB, Viola JPB, Bozza PT (2020) Lipid droplets: platforms with multiple functions in cancer hallmarks. Cell Death Dis 11:105. https:\/\/doi.org\/10.1038\/s41419-020-2297-3","journal-title":"Cell Death Dis"},{"key":"10598_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214489","author":"C Franco","year":"2022","unstructured":"Franco C, Sciatti E, Favero G, Bonomini F, Vizzardi E, Rezzani R (2022) Essential hypertension and oxidative stress: novel future perspectives. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232214489","journal-title":"Int J Mol Sci"},{"key":"10598_CR42","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.115.002661","volume":"9","author":"MW Bloom","year":"2016","unstructured":"Bloom MW, Hamo CE, Cardinale D et al (2016) Cancer therapy-related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging. Circ Heart Fail 9:e002661. https:\/\/doi.org\/10.1161\/circheartfailure.115.002661","journal-title":"Circ Heart Fail"},{"key":"10598_CR43","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/s0140-6736(20)31131-4","volume":"395","author":"B Williams","year":"2020","unstructured":"Williams B, Zhang Y (2020) Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19. Lancet 395:1671\u20131673. https:\/\/doi.org\/10.1016\/s0140-6736(20)31131-4","journal-title":"Lancet"},{"key":"10598_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-079980","volume":"14","author":"G Li","year":"2024","unstructured":"Li G, Zhang L, Liu M (2024) Meta-analysis on inflammation and autonomic nervous system of coronary heart disease combined with depression. BMJ Open 14:e079980. https:\/\/doi.org\/10.1136\/bmjopen-2023-079980","journal-title":"BMJ Open"},{"key":"10598_CR45","doi-asserted-by":"publisher","DOI":"10.2196\/32876","volume":"8","author":"K Hueniken","year":"2021","unstructured":"Hueniken K, Som\u00e9 NH, Abdelhack M, Taylor G, Elton Marshall T, Wickens CM, Hamilton HA, Wells S, Felsky D (2021) Machine learning-based predictive modeling of anxiety and depressive symptoms during 8 months of the COVID-19 global pandemic: repeated cross-sectional survey study. JMIR Ment Health 8:e32876. https:\/\/doi.org\/10.2196\/32876","journal-title":"JMIR Ment Health"},{"key":"10598_CR46","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jaccao.2024.05.015","volume":"6","author":"C McCracken","year":"2024","unstructured":"McCracken C, Condurache DG, Szabo L et al (2024) Predictive performance of cardiovascular risk scores in cancer survivors from the UK Biobank. JACC CardioOncol 6:575\u2013588. https:\/\/doi.org\/10.1016\/j.jaccao.2024.05.015","journal-title":"JACC CardioOncol"},{"key":"10598_CR47","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.jacc.2020.02.059","volume":"75","author":"EK Duran","year":"2020","unstructured":"Duran EK, Aday AW, Cook NR, Buring JE, Ridker PM, Pradhan AD (2020) Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease. J Am Coll Cardiol 75:2122\u20132135. https:\/\/doi.org\/10.1016\/j.jacc.2020.02.059","journal-title":"J Am Coll Cardiol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10598-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10598-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10598-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:41:26Z","timestamp":1776235286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10598-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10598"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10598-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocols of NHANES were approved by the institutional review board of the National Center for Health Statistics, CDC. ID: NCHS IRB\/ERB Protocol #2011\u201317, NCHS IRB\/ERB Protocol #2018\u201301. All procedures were conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"369"}}